Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1997 Feb;50(2):123–127. doi: 10.1136/jcp.50.2.123

Interstitial myofibroblasts: predictors of progression in membranous nephropathy.

I S Roberts 1, C Burrows 1, J H Shanks 1, M Venning 1, L J McWilliam 1
PMCID: PMC499736  PMID: 9155692

Abstract

AIMS: To determine the role of interstitial myofibroblasts in the progression of membranous nephropathy; and to assess the predictive value of quantifying myofibroblasts in determining long term renal outcome. METHODS: All cases of membranous nephropathy, diagnosed by renal biopsy at University Hospital of South Manchester between 1984 and 1987, were studied retrospectively. The biopsy specimens (n = 26) were reviewed and analysed morphometrically to measure interstitial volume as a proportion of the total volume of renal cortex, and numbers of interstitial myofibroblasts (cells positive for alpha-smooth muscle actin within the interstitium). Clinical data, with a follow up of seven to eight years, was available for 24 patients, and renal outcome was correlated with pathological changes in the initial diagnostic biopsy specimen. RESULTS: The number of myofibroblasts and interstitial volume were inversely correlated with creatinine clearance at the initial biopsy, and at the end of follow up. Percentage sclerosed glomeruli or stage of glomerular disease, assessed by electron microscopy, did not correlate with renal function at initial biopsy or during follow up. The number of myofibroblasts, but not interstitial volume, correlated with severity of proteinuria at initial biopsy. Of 15 biopsy specimens showing no or mild interstitial fibrosis, four showed a notable increase in the number of interstitial myofibroblasts. All of these patients developed chronic renal failure, compared with three of 11 patients whose specimens showed no or a mild increase in myofibroblast numbers. CONCLUSIONS: Interstitial myofibroblasts play a role in the development of interstitial fibrosis and progressive renal failure in membranous nephropathy. Increased numbers of myofibroblasts in biopsy specimens showing only mild fibrosis may predict subsequent chronic renal failure.

Full text

PDF
125

Images in this article

125Image
on p.125

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexopoulos E., Seron D., Hartley R. B., Nolasco F., Cameron J. S. Immune mechanisms in idiopathic membranous nephropathy: the role of the interstitial infiltrates. Am J Kidney Dis. 1989 May;13(5):404–412. doi: 10.1016/s0272-6386(89)80024-1. [DOI] [PubMed] [Google Scholar]
  2. Alpers C. E., Hudkins K. L., Floege J., Johnson R. J. Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. J Am Soc Nephrol. 1994 Aug;5(2):201–209. doi: 10.1681/ASN.V52201. [DOI] [PubMed] [Google Scholar]
  3. Austin H. A., 3rd, Boumpas D. T., Vaughan E. M., Balow J. E. Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int. 1994 Feb;45(2):544–550. doi: 10.1038/ki.1994.70. [DOI] [PubMed] [Google Scholar]
  4. Bohle A., Mackensen-Haen S., von Gise H. Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: a morphometric contribution. Am J Nephrol. 1987;7(6):421–433. doi: 10.1159/000167514. [DOI] [PubMed] [Google Scholar]
  5. Bohle A., Müller G. A., Wehrmann M., Mackensen-Haen S., Xiao J. C. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Kidney Int Suppl. 1996 May;54:S2–S9. [PubMed] [Google Scholar]
  6. Davison A. M., Cameron J. S., Kerr D. N., Ogg C. S., Wilkinson R. W. The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults. Clin Nephrol. 1984 Aug;22(2):61–67. [PubMed] [Google Scholar]
  7. Donadio J. V., Jr, Torres V. E., Velosa J. A., Wagoner R. D., Holley K. E., Okamura M., Ilstrup D. M., Chu C. P. Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int. 1988 Mar;33(3):708–715. doi: 10.1038/ki.1988.56. [DOI] [PubMed] [Google Scholar]
  8. Eddy A. A. Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol. 1994 Dec;5(6):1273–1287. doi: 10.1681/ASN.V561273. [DOI] [PubMed] [Google Scholar]
  9. Eddy A. A. Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol. 1989 Oct;135(4):719–733. [PMC free article] [PubMed] [Google Scholar]
  10. Fine L. G., Ong A. C., Norman J. T. Mechanisms of tubulo-interstitial injury in progressive renal diseases. Eur J Clin Invest. 1993 May;23(5):259–265. doi: 10.1111/j.1365-2362.1993.tb00771.x. [DOI] [PubMed] [Google Scholar]
  11. Floege J., Gröne H. J. Progression of renal failure: what is the role of cytokines? Nephrol Dial Transplant. 1995;10(9):1575–1586. [PubMed] [Google Scholar]
  12. Gabbiani G. The biology of the myofibroblast. Kidney Int. 1992 Mar;41(3):530–532. doi: 10.1038/ki.1992.75. [DOI] [PubMed] [Google Scholar]
  13. Goumenos D. S., Brown C. B., Shortland J., el Nahas A. M. Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Nephrol Dial Transplant. 1994;9(10):1418–1425. [PubMed] [Google Scholar]
  14. Hewitson T. D., Becker G. J. Interstitial myofibroblasts in IgA glomerulonephritis. Am J Nephrol. 1995;15(2):111–117. doi: 10.1159/000168813. [DOI] [PubMed] [Google Scholar]
  15. Honkanen E. Survival in idiopathic membranous glomerulonephritis. Clin Nephrol. 1986 Mar;25(3):122–128. [PubMed] [Google Scholar]
  16. Kuncio G. S., Neilson E. G., Haverty T. Mechanisms of tubulointerstitial fibrosis. Kidney Int. 1991 Mar;39(3):550–556. doi: 10.1038/ki.1991.63. [DOI] [PubMed] [Google Scholar]
  17. Lonnemann G., Shapiro L., Engler-Blum G., Müller G. A., Koch K. M., Dinarello C. A. Cytokines in human renal interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblasts. Kidney Int. 1995 Mar;47(3):837–844. doi: 10.1038/ki.1995.126. [DOI] [PubMed] [Google Scholar]
  18. Mallick N. P., Short C. D., Manos J. Clinical membranous nephropathy. Nephron. 1983;34(4):209–219. doi: 10.1159/000183018. [DOI] [PubMed] [Google Scholar]
  19. Murphy B. F., Fairley K. F., Kincaid-Smith P. S. Idiopathic membranous glomerulonephritis: long-term follow-up in 139 cases. Clin Nephrol. 1988 Oct;30(4):175–181. [PubMed] [Google Scholar]
  20. Ong A. C., Fine L. G. Loss of glomerular function and tubulointerstitial fibrosis: cause or effect? Kidney Int. 1994 Feb;45(2):345–351. doi: 10.1038/ki.1994.44. [DOI] [PubMed] [Google Scholar]
  21. Ong A. C., Fine L. G. Tubular-derived growth factors and cytokines in the pathogenesis of tubulointerstitial fibrosis: implications for human renal disease progression. Am J Kidney Dis. 1994 Feb;23(2):205–209. doi: 10.1016/s0272-6386(12)80973-5. [DOI] [PubMed] [Google Scholar]
  22. Ramzy M. H., Cameron J. S., Turner D. R., Neild G. H., Ogg C. S., Hicks J. The long-term outcome of idiopathic membranous nephropathy. Clin Nephrol. 1981 Jul;16(1):13–19. [PubMed] [Google Scholar]
  23. Sappino A. P., Schürch W., Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest. 1990 Aug;63(2):144–161. [PubMed] [Google Scholar]
  24. Skalli O., Schürch W., Seemayer T., Lagacé R., Montandon D., Pittet B., Gabbiani G. Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab Invest. 1989 Feb;60(2):275–285. [PubMed] [Google Scholar]
  25. Strutz F., Neilson E. G. The role of lymphocytes in the progression of interstitial disease. Kidney Int Suppl. 1994 Feb;45:S106–S110. [PubMed] [Google Scholar]
  26. Wehrmann M., Bohle A., Bogenschütz O., Eissele R., Freislederer A., Ohlschlegel C., Schumm G., Batz C., Gärtner H. V. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes. Clin Nephrol. 1989 Feb;31(2):67–76. [PubMed] [Google Scholar]
  27. Zhang G., Moorhead P. J., el Nahas A. M. Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol. 1995 Sep-Oct;3(5):308–318. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES